Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Number 2—February 2025
Dispatch

Comparison of Contemporary and Historic Highly Pathogenic Avian Influenza A(H5N1) Virus Replication in Human Lung Organoids

Meaghan Flagg1, Brandi N. Williamson1, Johan A. Ortiz-Morales, Tessa R. Lutterman, and Emmie de WitComments to Author 
Author affiliation: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA

Main Article

Figure 2

Induction of ISGs in a comparison of contemporary and historic highly pathogenic avian influenza A(H5N1) virus replication in human lung organoids. A) ISG15; B) ISG20; C) interferon-induced transmembrane 3; D) interferon-induced protein with tetratricopeptide 1; E) myxovirus resistance 1; F) 2′-5′-oligoadenylate synthetase 1; G) retinoic acid–inducible 1. We infected ihLO and hLO as described in Figure 1. We extracted RNA from 2.5 × 104 cells by using the QIAGEN RNeasy kit (QIAGEN, https://www.qiagen.com) following the tissue extraction instructions. We ran quantitative reverse transcription PCR by using primers (Integrated DNA Technologies, https://www.idtdna.com) to detect ISGs. Data were normalized to an internal control (ACTB), and fold change was calculated relative to timepoint-matched mock-infected controls. Mean fold change is reported for 6 ihLO and 3 hLO biologic replicates. Statistical analysis was performed using 2-way analysis of variance followed by Dunnett posttest; p values <0.05 for comparisons of infected versus mock samples are indicated. hLOs, adult stem cell–derived human lung organoids; HPAI, highly pathogenic avian influenza; ihLO, iPSC-derived human lung organoids; iPSCs, induced pluripotent stem cells; ISGs, interferon stimulated genes; LDH, lactate dehydrogenase.

Figure 2. Induction of ISGs in a comparison of contemporary and historic highly pathogenic avian influenza A(H5N1) virus replication in human lung organoids. A) ISG15; B) ISG20; C) interferon-induced transmembrane 3; D) interferon-induced protein with tetratricopeptide 1; E) myxovirus resistance 1; F) 2′-5′-oligoadenylate synthetase 1; G) retinoic acid–inducible 1. We infected ihLO and hLO as described in [[ANCHOR###F1###Figure 1###Anchor]]. We extracted RNA from 2.5 × 104 cells by using the QIAGEN RNeasy kit (QIAGEN, https://www.qiagen.com) following the tissue extraction instructions. We ran quantitative reverse transcription PCR by using primers (Integrated DNA Technologies, https://www.idtdna.com) to detect ISGs. Data were normalized to an internal control (ACTB), and fold change was calculated relative to timepoint-matched mock-infected controls. Mean fold change is reported for 6 ihLO and 3 hLO biologic replicates. Statistical analysis was performed using 2-way analysis of variance followed by Dunnett posttest; p values <0.05 for comparisons of infected versus mock samples are indicated. hLOs, adult stem cell–derived human lung organoids; HPAI, highly pathogenic avian influenza; ihLO, iPSC-derived human lung organoids; iPSCs, induced pluripotent stem cells; ISGs, interferon stimulated genes; LDH, lactate dehydrogenase.

Main Article

1These authors contributed equally to this article.

Page created: December 30, 2024
Page updated: January 31, 2025
Page reviewed: January 31, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external